The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System
Open accessThe DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Abstract
Estrogen has important effects on cardiovascular function including regulation of vascular function, blood pressure, endothelial relaxation, and the development of hypertrophy and cardioprotection. However, the mechanisms by which estrogen mediates these effects are still poorly understood. As detailed in this review, estrogen can regulate transcription by binding to 2 nuclear receptors, ERα and ERβ, which differentially regulate gene transcription. ERα and ERβ regulation of gene transcription is further modulated by tissue-specific coactivators and corepressors. Estrogen can bind to ERα and ERβ localized at the plasma membrane as well as G-protein–coupled estrogen receptor to initiate membrane delimited signaling, which enhances kinase signaling pathways that can have acute and long-term effects. The kinase signaling pathways can also mediate transcriptional changes and can synergize with the ER to regulate cell function. This review will summarize the beneficial effects of estrogen in protecting the cardiovascular system through ER-dependent mechanisms with an emphasis on the role of the recently described ER membrane signaling mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004) · Physiological Reviews · doi:10.1152/physrev.00041.2003 · Cited by 3,471 · cited 1×
“Normally, VSMC proliferation is slow; however, during stress, such as atherosclerosis or hypertension, these cells increase the rate of proliferation and migration.(138) Estrogen decreases VSMC proliferation after injury.”
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431 · cited 1×
“protein-1 activity is regulated via MAPK-mediated phosphorylation.(152) Estrogen can activate MAPK signaling that results”
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302 · cited 1×
“Two independent groups found that estrogen can directly bind to GPER at the membrane in monkey kidney fibroblast cells and breast cancer cells.(72,118) Haas et al(120) later discovered GPER expression in VSMC of human arteries and veins and confirmed that this novel receptor is regulated by estrogen.”
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930 · cited 1×
“Large randomized clinical trials did not show a benefit with hormonereplacement therapy.(6,7) However, a recent update of the woman health initiative examined different age groups and concluded that hormone-replacement therapy “has a harmful effect on coronary heart disease among older women, whereas the results in yo…”
Policy: NIH to balance sex in cell and animal studies
Clayton, J. A., & Collins, F. S. (2014) · Nature · doi:10.1038/509282a · Cited by 1,816 · cited 1×
“the National Institutes of Health has recently called for the inclusion of both sexes in preclinical trials.(11) Without a better”
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436 · cited 1×
“Indeed, mice treated with estrogen showed increased eNOS activity and decreased vascular leukocyte accumulation after I/R injury, and this vascular protective effect of estrogen was abolished in the presence of inhibitors of PI3K or eNOS.(92) ERα can also interact with the G proteins Gαi and Gβγ through amino acids 25…”
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407 · cited 1×
“Two independent groups found that estrogen can directly bind to GPER at the membrane in monkey kidney fibroblast cells and breast cancer cells.(72,118) Haas et al(120) later discovered GPER expression in VSMC of human arteries and veins and confirmed that this novel receptor is regulated by estrogen.”
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Estrogen and coronary heart disease in women
Barrett-Connor, E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460140089033 · Cited by 1,241
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,208
Molecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146 · cited 1×
“recruits coactivators in endometrium, but it is an antagonist in breast recruiting corepressors.(42) Hall et al(16) provide a more”
Molecular and Cellular Basis of Cardiovascular Gender Differences
Mendelsohn, M. E., & Karas, R. H. (2005) · Science · doi:10.1126/science.1112062 · Cited by 1,101 · cited 1×
“Premenopausal women have reduced cardiovascular disease, and the occurrence increases after menopause.(1,2) Furthermore, many studies in animal models have reported less hypertrophy and less ischemia–reperfusion (I/R) injury in females compared with males.”
Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J.-A., & Korach, K. S. (1997) · Endocrinology · doi:10.1210/endo.138.11.5496 · Cited by 978
Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., & Shaul, P. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5347 · Cited by 923 · cited 2×
“ized at the plasma membrane initiate rapid signal transduction through kinase cascades involving PI3K,(91,92) mitogen-activated protein kinase (MAPK),(93,94) and eNOS activation.(95,96) Rapid sig-”
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C. G., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuck, N. P., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 818 · cited 1×
“Several studies using the selective GPER agonist (G-1) were conducted confirming its ability to initiate vascular relaxation.(129) Acute G-1 treatment induces relaxation on porcine coronary arteries,(130) on rat aorta,(131) and human internal mammary arteries.”
Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
PIETRAS, R. J., & SZEGO, C. M. (1977) · Nature · doi:10.1038/265069a0 · Cited by 691
Haynes, M. P., Sinha, D., Russell, K. S., Collinge, M., Fulton, D., Morales-Ruiz, M., Sessa, W. C., & Bender, J. R. (2000) · Circulation Research · doi:10.1161/01.res.87.8.677 · Cited by 575 · cited 2×
“Initial studies showed that an estrogen–BSA conjugate stimulates eNOS phosphorylation in cultured EC.75 Estrogen can activate eNOS by multiple signaling pathways as illustrated in Figure 3A.”
Estrogen Modulation of Endothelial Nitric Oxide Synthase
Chambliss, K. L., & Shaul, P. W. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0045 · Cited by 569 · cited 1×
“mitoylation, which has been shown to increase association of the receptor with the plasma membrane.(30,71)”
Nature of Functional Estrogen Receptors at the Plasma Membrane
Pedram, A., Razandi, M., & Levin, E. R. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0525 · Cited by 522 · cited 1×
“ERα and ERβ Both Localize to the Plasma Membrane It is estimated that ≈5% to 10% of total ERs are localized to the plasma membrane.(77) The relative amount of ERα and ERβ”
Coregulator codes of transcriptional regulation by nuclear receptors
Rosenfeld, M. G., & Glass, C. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100041200 · Cited by 509
Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
Iafrati, M. D., Karas, R. H., Aronovitz, M., Kim, S., Sullivan, T. R., Lubahn, D. B., O'Donnell, T. F., Korach, K. S., & Mendelsohn, M. E. (1997) · Nature Medicine · doi:10.1038/nm0597-545 · Cited by 486
Modulation of Antioxidant Enzyme Expression and Function by Estrogen
Strehlow, K., Rotter, S., Wassmann, S., Adam, O., Grohé, C., Laufs, K., Böhm, M., & Nickenig, G. (2003) · Circulation Research · doi:10.1161/01.res.0000082334.17947.11 · Cited by 483
Post, W. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00153-4 · Cited by 482
Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β
Zhu, Y., Bian, Z., Lu, P., Karas, R. H., Bao, L., Cox, D., Hodgin, J., Shaul, P. W., Thorén, P., Smithies, O., et al. (2002) · Science · doi:10.1126/science.1065250 · Cited by 482 · cited 1×
“There were initially reports using a first generation ERα knockout mouse, which was later found to express a truncated ERα protein which could mediate estrogen-dependent transcriptional activity, suggesting that ERα was not required to mediate the vascular injury response.(57,142) However, later studies using an ERα k…”
Lindberg, M. K., Movérare, S., Skrtic, S., Gao, H., Dahlman-Wright, K., Gustafsson, J.-A., & Ohlsson, C. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0206 · Cited by 479
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
Castoria, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6050 · Cited by 468
Li, L., Haynes, M. P., & Bender, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831079100 · Cited by 465 · cited 16×
“In cardiomyocytes, Ullrich et al128 have shown that estrogendependent intracellular calcium signaling is independent of classic ERs: ERα and ERβ.”
InfluentialFilardo, E., Quinn, J., Pang, Y., Graeber, C., Shaw, S., Dong, J., & Thomas, P. (2007) · Endocrinology · doi:10.1210/en.2006-1605 · Cited by 450
A Conserved Mechanism for Steroid Receptor Translocation to the Plasma Membrane
Pedram, A., Razandi, M., Sainson, R. C. A., Kim, J. K., Hughes, C. C., & Levin, E. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611877200 · Cited by 446 · cited 17×
“In cardiomyocytes, Ullrich et al128 have shown that estrogendependent intracellular calcium signaling is independent of classic ERs: ERα and ERβ.”
InfluentialPalmitoylation-dependent Estrogen Receptor α Membrane Localization: Regulation by 17β-Estradiol
Acconcia, F., Ascenzi, P., Bocedi, A., Spisni, E., Tomasi, V., Trentalance, A., Visca, P., & Marino, M. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0547 · Cited by 438
Chambliss, K. L., Yuhanna, I. S., Mineo, C., Liu, P., German, Z., Sherman, T. S., Mendelsohn, M. E., Anderson, R. G. W., & Shaul, P. W. (2000) · Circulation Research · doi:10.1161/01.res.87.11.e44 · Cited by 415 · cited 2×
“mitoylation, which has been shown to increase association of the receptor with the plasma membrane.(30,71)”
Estrogen biology: New insights into GPER function and clinical opportunities
Prossnitz, E. R., & Barton, M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.02.002 · Cited by 400
Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women
Hodis, H. N., Mack, W. J., Azen, S. P., Lobo, R. A., Shoupe, D., Mahrer, P. R., Faxon, D. P., Cashin-Hemphill, L., Sanmarco, M. E., French, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030830 · Cited by 386
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity
Haas, E., Bhattacharya, I., Brailoiu, E., Damjanović, M., Brailoiu, G. C., Gao, X., Mueller-Guerre, L., Marjon, N. A., Gut, A., Minotti, R., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190892 · Cited by 373 · cited 2×
“Acute G-1 treatment induces relaxation on porcine coronary arteries,(130) on rat aorta,(131) and human internal mammary arteries.(132) Infusion of G-1 to normotensive rats results in an acute reduction in blood pressure.”
Estrogen Receptor-α Mediates the Protective Effects of Estrogen Against Vascular Injury
Pare, G., Krust, A., Karas, R. H., Dupont, S., Aronovitz, M., Chambon, P., & Mendelsohn, M. E. (2002) · Circulation Research · doi:10.1161/01.res.0000021114.92282.fa · Cited by 369 · cited 1×
“However, later studies using an ERα knockout mouse, which is deficient in ERα, clearly demonstrated that ERα is required for the antiproliferative effects of estrogen.(140) There are also some data, using GPER agonist, that suggest that activation of GPER can also play a role in the estrogen effect on vascular injury.”
G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane
Funakoshi, T., Yanai, A., Shinoda, K., Kawano, M. M., & Mizukami, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.191 · Cited by 351
Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression.
Caulin-Glaser, T., Watson, C. A., Pardi, R., & Bender, J. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118774 · Cited by 342
Discovery of Three Novel G-Protein-Coupled Receptor Genes
O'Dowd, B. F., Nguyen, T., Marchese, A., Cheng, R., Lynch, K. R., Heng, H. H. Q., Kolakowski, L. F., & George, S. R. (1998) · Genomics · doi:10.1006/geno.1998.5095 · Cited by 334
Plasma Membrane Estrogen Receptors Exist and Functions as Dimers
Razandi, M., Pedram, A., Merchenthaler, I., Greene, G. L., & Levin, E. R. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0115 · Cited by 330
Lagranha, C. J., Deschamps, A., Aponte, A., Steenbergen, C., & Murphy, E. (2010) · Circulation Research · doi:10.1161/circresaha.109.213645 · Cited by 326
Self-citationRegulation of Estrogen Rapid Signaling through Arginine Methylation by PRMT1
Le Romancer, M., Treilleux, I., Leconte, N., Robin-Lespinasse, Y., Sentis, S., Bouchekioua-Bouzaghou, K., Goddard, S., Gobert-Gosse, S., & Corbo, L. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.025 · Cited by 324 · cited 16×
“In cardiomyocytes, Ullrich et al128 have shown that estrogendependent intracellular calcium signaling is independent of classic ERs: ERα and ERβ.”
InfluentialRazandi, M., Alton, G., Pedram, A., Ghonshani, S., Webb, P., & Levin, E. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1633-1646.2003 · Cited by 323
Haynes, M. P., Li, L., Sinha, D., Russell, K. S., Hisamoto, K., Baron, R., Collinge, M., Sessa, W. C., & Bender, J. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210828200 · Cited by 304
Curtis, S. W., Washburn, T., Sewall, C., DiAugustine, R., Lindzey, J., Couse, J. F., & Korach, K. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12626 · Cited by 304 · cited 17×
“In cardiomyocytes, Ullrich et al128 have shown that estrogendependent intracellular calcium signaling is independent of classic ERs: ERα and ERβ.”
InfluentialPyo Kim, H., Young Lee, J., Kim Jeong, J., Won Bae, S., Kyu Lee, H., & Jo, I. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1348 · Cited by 300
Klinge, C. M., Blankenship, K. A., Risinger, K. E., Bhatnagar, S., Noisin, E. L., Sumanasekera, W. K., Zhao, L., Brey, D. M., & Keynton, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411565200 · Cited by 296
Genomic and nongenomic effects of estrogen in the vasculature
Mendelsohn, M. E. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02418-9 · Cited by 294 · cited 1×
“Both the ERα and ERβ have been localized in the cardiovascular system.(157) The expression level of ERs seems to vary with the sex.”
Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
Lantin-Hermoso, R. L., Rosenfeld, C. R., Yuhanna, I. S., German, Z., Chen, Z., & Shaul, P. W. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.273.1.l119 · Cited by 284 · cited 1×
“ized at the plasma membrane initiate rapid signal transduction through kinase cascades involving PI3K,(91,92) mitogen-activated protein kinase (MAPK),(93,94) and eNOS activation.(95,96) Rapid sig-”
Jakacka, M., Ito, M., Weiss, J., Chien, P.-Y., Gehm, B. D., & Jameson, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008384200 · Cited by 284
Mitochondrial localization of ERα and ERβ in human MCF7 cells
Chen, J. Q., Delannoy, M., Cooke, C., & Yager, J. D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00508.2003 · Cited by 272
Lu, Q., Pallas, D. C., Surks, H. K., Baur, W. E., Mendelsohn, M. E., & Karas, R. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407492101 · Cited by 266 · cited 2×
“Estrogen promotes the formation of a complex containing ERα, striatin, and Gαi leading to the activation of extracellularsignal-regulated kinases 1/2, Akt and eNOS pathways stimulating EC migration.(89,104) Besides nitric oxide generation, the nongenomic ER signaling pathway also modulates intracellular calcium homeos…”
Muscle GLUT4 regulation by estrogen receptors ERβ and ERα
Barros, R. P. A., Machado, U. F., Warner, M., & Gustafsson, J.-Å. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510391103 · Cited by 263
ERβ Has Nongenomic Action in Caveolae
Chambliss, K. L., Yuhanna, I. S., Anderson, R. G. W., Mendelsohn, M. E., & Shaul, P. W. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0827 · Cited by 263
Adlanmerini, M., Solinhac, R., Abot, A., Fabre, A., Raymond-Letron, I., Guihot, A.-L., Boudou, F., Sautier, L., Vessières, E., Kim, S. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322057111 · Cited by 260 · cited 1×
“offer insight into the collaboration between non-nuclear and nuclear ERα and ERβ signaling.(149,150) Pedram et al(149) found that nuclear ERα and ERβ alone are not able to maintain”
Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats
Deschamps, A. M., & Murphy, E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00283.2009 · Cited by 252
Self-citationChambliss, K. L., Wu, Q., Oltmann, S., Konaniah, E. S., Umetani, M., Korach, K. S., Thomas, G. D., Mineo, C., Yuhanna, I. S., Kim, S. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38291 · Cited by 250 · cited 1×
“Estrogen also has a role in regulating proliferation of vascular ECs, thus preventing excessive EC proliferation that can occur during atherosclerosis.(103) Treatment with G-1 reduced DNA synthesis and endothelial proliferation by blocking the transition between G2 and M phases of the cell cycle in mouse microvascular…”
Hewitt, S. C., Deroo, B. J., Hansen, K., Collins, J., Grissom, S., Afshari, C. A., & Korach, K. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0146 · Cited by 247 · cited 1×
“as mentioned, estrogen can act in a time- and tissue-dependent manner.(44) For example, in endothelial cells, ERα upregulates”
Harrington, W. R., Kim, S. H., Funk, C. C., Madak-Erdogan, Z., Schiff, R., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0186 · Cited by 246
Skavdahl, M., Steenbergen, C., Clark, J., Myers, P., Demianenko, T., Mao, L., Rockman, H. A., Korach, K. S., & Murphy, E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2004 · Cited by 216
Self-citationHodges, Y. K., Tung, L., Yan, X.-D., Graham, J. D., Horwitz, K. B., & Horwitz, L. D. (2000) · Circulation · doi:10.1161/01.cir.101.15.1792 · Cited by 202
Bopassa, J. C., Eghbali, M., Toro, L., & Stefani, E. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00588.2009 · Cited by 197 · cited 1×
“Also, GPER activation has been shown to inhibit mitochondria permeability transition pore opening after I/R injury, thereby protecting hearts from cell death.(147) It was also reported that G-1 can reduce the inflammatory response in global ischemic injury.”
Gavin, K. M., Seals, D. R., Silver, A. E., & Moreau, K. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0278 · Cited by 194 · cited 1×
“postmenopausal women is 33% lower than in the late follicular phase in premenopausal women.(162,163) In astrocytes, using immunohistochemistry and Western blot analysis, Arimoto et al(164) reported an increase in ERα levels with aging.”
Nuedling, S. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00093-0 · Cited by 190
Estrogen Inhibits Cardiac Hypertrophy: Role of Estrogen Receptor-β to Inhibit Calcineurin
Pedram, A., Razandi, M., Lubahn, D., Liu, J., Vannan, M., & Levin, E. R. (2008) · Endocrinology · doi:10.1210/en.2008-0133 · Cited by 189
Walker, H. A., Dean, T. S., Sanders, T. A. B., Jackson, G., Ritter, J. M., & Chowienczyk, P. J. (2001) · Circulation · doi:10.1161/01.cir.103.2.258 · Cited by 189 · cited 1×
“naling by estrogen action was shown to lead to increased nitric oxide within minutes after addition of estrogen.(97) Nitric oxide”
Increased Expression of the Cardiac L-type Calcium Channel in Estrogen Receptor–deficient Mice
Johnson, B. D., Zheng, W., Korach, K. S., Scheuer, T., Catterall, W. A., & Rubanyi, G. M. (1997) · The Journal of General Physiology · doi:10.1085/jgp.110.2.135 · Cited by 188
Membrane-Localized Estrogen Receptor α Is Required for Normal Organ Development and Function
Pedram, A., Razandi, M., Lewis, M., Hammes, S., & Levin, E. R. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.04.016 · Cited by 181
S-palmitoylation modulates human estrogen receptor-α functions
Acconcia, F., Ascenzi, P., Fabozzi, G., Visca, P., & Marino, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.129 · Cited by 180
Estrogen Induces Vascular Wall Dilation
Guo, X., Razandi, M., Pedram, A., Kassab, G., & Levin, E. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501244200 · Cited by 179
Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
Huang, B., Omoto, Y., Iwase, H., Yamashita, H., Toyama, T., Coombes, R. C., Filipovic, A., Warner, M., & Gustafsson, J.-Å. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323719111 · Cited by 179
Lindsey, S. H., Cohen, J. A., Brosnihan, K. B., Gallagher, P. E., & Chappell, M. C. (2009) · Endocrinology · doi:10.1210/en.2008-1664 · Cited by 179
Madak-Erdogan, Z., Kieser, K. J., Kim, S. H., Komm, B., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0059 · Cited by 178
Gender Differences of Cardiovascular Disease: New Perspectives for Estrogen Receptor Signaling
Meyer, M. R., Haas, E., & Barton, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000223064.62762.0b · Cited by 178
Cell-Surface Estrogen Receptors Mediate Calcium-Dependent Nitric Oxide Release in Human Endothelia
Stefano, G. B., Prevot, V., Beauvillain, J.-C., Cadet, P., Fimiani, C., Welters, I., Fricchione, G. L., Breton, C., Lassalle, P., Salzet, M., et al. (2000) · Circulation · doi:10.1161/01.cir.101.13.1594 · Cited by 170 · cited 1×
“Besides nitric oxide generation, the nongenomic ER signaling pathway also modulates intracellular calcium homeostasis at physiological estrogen concentration (10 mol/L) in human EC, causing a rapid increase in intracellular calcium.(105) Treatment with estrogen conjugated to BSA caused a rise in calcium concentration…”
Pendaries, C., Darblade, B., Rochaix, P., Krust, A., Chambon, P., Korach, K. S., Bayard, F., & Arnal, J.-F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042688499 · Cited by 170
O’Lone, R., Knorr, K., Jaffe, I. Z., Schaffer, M. E., Martini, P. G. V., Karas, R. H., Bienkowska, J., Mendelsohn, M. E., & Hansen, U. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0497 · Cited by 169
Figtree, G. A., McDonald, D., Watkins, H. C., & Channon, K. M. (2003) · Circulation · doi:10.1161/01.cir.0000043805.11780.f5 · Cited by 168
Haas, E., Meyer, M. R., Schurr, U., Bhattacharya, I., Minotti, R., Nguyen, H. H., Heigl, A., Lachat, M., Genoni, M., & Barton, M. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089995 · Cited by 165
Genomic and non-genomic effects of estrogens on endothelial cells*1
SIMONCINI, T. (2004) · Steroids · doi:10.1016/j.steroids.2004.05.009 · Cited by 163 · cited 1×
“It is established that physiological concentrations of estrogen can have rapid effects, which occur independent of protein synthesis or gene activation, and it is generally accepted that these acute effects of estrogen are transmitted by signaling pathways through activation of ERs localized at the plasma membrane.(68…”
Nickenig, G., Strehlow, K., Wassmann, S., Bäumer, A. T., Albory, K., Sauer, H., & Böhm, M. (2000) · Circulation · doi:10.1161/01.cir.102.15.1828 · Cited by 161
Wingrove, C. S., Garr, E., Godsland, I. F., & Stevenson, J. C. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00097-5 · Cited by 160
Sudhir, K., Chou, T. M., Mullen, W. L., Hausmann, D., Collins, P., Yock, P. G., & Chatterjee, K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00248-3 · Cited by 159
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity
Thomas, R. S., Sarwar, N., Phoenix, F. A., Coombes, R. C., & Ali, S. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0165 · Cited by 159
Gender differences in the expression of heat shock proteins: the effect of estrogen
Voss, M. R., Stallone, J. N., Li, M., Cornelussen, R. N. M., Knuefermann, P., & Knowlton, A. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01000.2002 · Cited by 156
Mendelsohn, M. E. (2000) · Circulation Research · doi:10.1161/01.res.87.11.956 · Cited by 154 · cited 1×
“vasodilatation, and platelet inhibition, resulting in prevention of thrombus formation and leukocyte–EC adhesion.(80,98)”
The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function
Meyer, M. R., Prossnitz, E. R., & Barton, M. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.06.003 · Cited by 154 · cited 1×
“It has also been shown that estrogen-GPER activation protects against cardiac I/R injury.(145) Deschamps and Murphy(146) demonstrated that acute treatment of perfused rat heart with G-1 is cardioprotective, as it improved the contractile dysfunction after ischemia.”
Direct Interactions with Gαi and Gβγ Mediate Nongenomic Signaling by Estrogen Receptor α
Kumar, P., Wu, Q., Chambliss, K. L., Yuhanna, I. S., Mumby, S. M., Mineo, C., Tall, G. G., & Shaul, P. W. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0360 · Cited by 150 · cited 2×
“Finally, immunoprecipitation studies demonstrated that amino acids 251 to 260 and 271 to 595 of ERα bind directly to Gαi and Gβγ.(84) These modifications and their”
Stirone, C., Boroujerdi, A., Duckles, S. P., & Krause, D. N. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.004465 · Cited by 148
Estrogen Inhibits Cardiomyocyte Hypertrophy in Vitro
Pedram, A., Razandi, M., Aitkenhead, M., & Levin, E. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414409200 · Cited by 143
Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium.
Jun, S. S., Chen, Z., Pace, M. C., & Shaul, P. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2034 · Cited by 142
Molecular and Cellular Determinants of Estrogen Receptor α Expression
Pinzone, J. J., Stevenson, H., Strobl, J. S., & Berg, P. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4605-4612.2004 · Cited by 142
Estrogen Causes Dynamic Alterations in Endothelial Estrogen Receptor Expression
Ihionkhan, C. E., Chambliss, K. L., Gibson, L. L., Hahner, L., Mendelsohn, M. E., & Shaul, P. W. (2002) · Circulation Research · doi:10.1161/01.res.0000038304.62046.4c · Cited by 140
Activation of estrogen receptor-α protects the in vivo rabbit heart from ischemia-reperfusion injury
Booth, E. A., Obeid, N. R., & Lucchesi, B. R. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00479.2005 · Cited by 136
Marino, M., Acconcia, F., Bresciani, F., Weisz, A., & Trentalance, A. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-03-0153 · Cited by 135 · cited 1×
“in enhanced activator protein-1 DNA binding and lead to gene expression activation.(153,154) Also, the activation of the PI3K-”
Estrogen and coronary heart disease in women
Barrett-Connor, E. L., & Bush, T. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90420-n · Cited by 133 · cited 1×
“Premenopausal women have reduced cardiovascular disease, and the occurrence increases after menopause.(1,2) Furthermore, many studies in animal models have reported less hypertrophy and less ischemia–reperfusion (I/R) injury in females compared with males.”
Sandén, C., Broselid, S., Cornmark, L., Andersson, K. A., Daszkiewicz-Nilsson, J., Mårtensson, U. E. A., Olde, B., & Leeb-Lundberg, L. M. F. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.069500 · Cited by 132
Estrogen Contributes to Gender Differences in Mouse Ventricular Repolarization
Saito, T., Ciobotaru, A., Bopassa, J. C., Toro, L., Stefani, E., & Eghbali, M. (2009) · Circulation Research · doi:10.1161/circresaha.108.190041 · Cited by 126
Estrogen Receptor β Protects the Murine Heart Against Left Ventricular Hypertrophy
Babiker, F. A., Lips, D. J., Meyer, R., Delvaux, E., Zandberg, P., Janssen, B. J., van Eys, G. J. J. M., Grohé, C., & Doevendans, P. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000223344.11128.23 · Cited by 126
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets
Klinge, C. M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.035 · Cited by 123
Meyer, M. R., Baretella, O., Prossnitz, E. R., & Barton, M. (2010) · Pharmacology · doi:10.1159/000315497 · Cited by 121 · cited 2×
“Endothelium denudation or treatment with L-N-nitroarginine methyl ester, a NOS inhibitor, completely abolished the relaxation of porcine coronary arteries induced by G-1 action, consistent with a role for eNOS activation.(125) In contrast, several other studies demonstrated that G-1 treatment can still have an effect…”
Garcia Dos Santos, E. (2002) · Endocrinology · doi:10.1210/en.143.3.930 · Cited by 120 · cited 1×
“in enhanced activator protein-1 DNA binding and lead to gene expression activation.(153,154) Also, the activation of the PI3K-”
Cheng, S.-B., Quinn, J. A., Graeber, C. T., & Filardo, E. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224071 · Cited by 120
Estrogen Reduces Lipid Content in the Liver Exclusively from Membrane Receptor Signaling
Pedram, A., Razandi, M., O’Mahony, F., Harvey, H., Harvey, B. J., & Levin, E. R. (2013) · Science Signaling · doi:10.1126/scisignal.2004013 · Cited by 118
Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries
Broughton, B. R. S., Miller, A. A., & Sobey, C. G. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00878.2009 · Cited by 116
Kararigas, G., Bito, V., Tinel, H., Becher, E., Baczkó, I., Knosalla, C., Albrecht-Küpper, B. E., Sipido, K. R., & Regitz‐Zagrosek, V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.054 · Cited by 115 · cited 1×
“gen-dependent genes are regulated in a sex-specific manner confirming that estrogen effects are tissue and sex specific.(36)”
Burns, K. A., Li, Y., Arao, Y., Petrovich, R. M., & Korach, K. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187773 · Cited by 112
YAN, L., GE, H., LI, H., LIEBER, S., NATIVIDAD, F., RESUELLO, R., KIM, S., AKEJU, S., SUN, A., & LOO, K. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.06.012 · Cited by 111
Lindsey, S. H., Carver, K. A., Prossnitz, E. R., & Chappell, M. C. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182135f1c · Cited by 107 · cited 1×
“Furthermore, GPER agonist treatment induces vasodilation in female rats.(134) It has been suggested that G-1 results in 30% to 40% vasorelaxation in vivo(135); however, the mechanism mediating this effect is poorly understood.”
Nuedling, S., Karas, R. H., Mendelsohn, M. E., Katzenellenbogen, J. A., Katzenellenbogen, B. S., Meyer, R., Vetter, H., & Grohé, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02675-8 · Cited by 107 · cited 1×
“endothelial nitric oxide synthase (eNOS), whereas in cardiac muscle, ERβ mediates upregulation of eNOS.(45,46) Also,”
Yu, X., Ma, H., Barman, S. A., Liu, A. T., Sellers, M., Stallone, J. N., Prossnitz, E. R., White, R. E., & Han, G. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00037.2011 · Cited by 107 · cited 1×
“In contrast, several other studies demonstrated that G-1 treatment can still have an effect on vasorelaxation in endothelium-denuded aorta(131) and porcine coronary arteries.(136) It was also shown that inhibition of eNOS does not affect this vasodilation response.”
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective
Nikolic, I., Liu, D., Bell, J. A., Collins, J. B., Steenbergen, C., & Murphy, E. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.01.014 · Cited by 106 · cited 1×
“nist primarily led to the upregulation of gene expression with only a few genes downregulated.(41) These conflicting results”
Self-citationSimoncini, T., Rabkin, E., & Liao, J. K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000053846.71621.93 · Cited by 105 · cited 1×
“ERα and ERβ signaling ERα was first shown to localize to the plasma membrane and to activate phosphatidylinositol-3-OH kinase (PI3K) signaling.(90) ERα and ERβ have been shown to play important roles in mod-”
Jessup, J. A., Lindsey, S. H., Wang, H., Chappell, M. C., & Groban, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015433 · Cited by 104 · cited 1×
“Lewis rats, G-1 treatment leads to improved cardiac relaxation and reduced myocyte hypertrophy.(133) Furthermore, GPER agonist treatment induces vasodilation in female rats.”
Bernelot Moens, S. J., Schnitzler, G. R., Nickerson, M., Guo, H., Ueda, K., Lu, Q., Aronovitz, M. J., Nickerson, H., Baur, W. E., Hansen, U., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.124529 · Cited by 103 · cited 2×
“Estrogen promotes the formation of a complex containing ERα, striatin, and Gαi leading to the activation of extracellularsignal-regulated kinases 1/2, Akt and eNOS pathways stimulating EC migration.(89,104) Besides nitric oxide generation, the nongenomic ER signaling pathway also modulates intracellular calcium homeos…”
Vascular endothelial function in health and diseases
Khazaei, M., Moien-afshari, F., & Laher, I. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2008.02.002 · Cited by 99 · cited 1×
“and endothelial dysfunction is associated with an increased cardiovascular risk.(99) The rapid activation of eNOS is an im-”
Membrane association of estrogen receptor α mediates estrogen effect on MAPK activation
Zhang, Z., Maier, B., Santen, R. J., & Song, R. X.-D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00348-0 · Cited by 97
Estrogen Attenuates Endothelin-1 Production by Bovine Endothelial Cells via Estrogen Receptor
Akishita, M., Kozaki, K., Eto, M., Yoshizumi, M., Ishikawa, M., Toba, K., Orimo, H., & Ouchi, Y. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9409 · Cited by 96
Razandi, M., Pedram, A., & Levin, E. R. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01354-09 · Cited by 89
Estrogen regulates histone deacetylases to prevent cardiac hypertrophy
Pedram, A., Razandi, M., Narayanan, R., Dalton, J. T., McKinsey, T. A., & Levin, E. R. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-08-0444 · Cited by 87
Li, L., Hisamoto, K., Kim, K. H., Haynes, M. P., Bauer, P. M., Sanjay, A., Collinge, M., Baron, R., Sessa, W. C., & Bender, J. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704315104 · Cited by 86 · cited 1×
“ERα 46 has been found coimmunoprecipitated with eNOS(86) leading to eNOS activation and nitric oxide release.(87)”
PELZER, T., JAZBUTYTE, V, HU, K., SEGERER, S., NAHRENDORF, M., NORDBECK, P., BONZ, A., MUCK, J., FRITZEMEIER, K., & HEGELEHARTUNG, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.035 · Cited by 84
Estradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall
Liu, Z., Gou, Y., Zhang, H., Zuo, H., Zhang, H., Liu, Z., & Yao, D. (2014) · Redox Biology · doi:10.1016/j.redox.2014.11.001 · Cited by 84 · cited 1×
“in a decrease in reactive oxygen species generation with lower mitochondrial dysfunction and vascular damage.(49) The Table summarizes the known functions associated with ERα and ERβ gene regulations.”
Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury
Weil, B. R., Manukyan, M. C., Herrmann, J. L., Wang, Y., Abarbanell, A. M., Poynter, J. A., & Meldrum, D. R. (2010) · Surgery · doi:10.1016/j.surg.2010.03.011 · Cited by 83 · cited 1×
“It was also reported that G-1 can reduce the inflammatory response in global ischemic injury.(148) The discovery that GPER activation of acute signaling mechanisms results in myocardial protection provides the exciting possibility that GPER agonists can be used to initiate cardioprotection while avoiding the side effe…”
Dworatzek, E., Mahmoodzadeh, S., Schubert, C., Westphal, C., Leber, J., Kusch, A., Kararigas, G., Fliegner, D., Moulin, M., Ventura-Clapier, R., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu065 · Cited by 79
Wynne, F. L., Payne, J. A., Cain, A. E., Reckelhoff, J. F., & Khalil, R. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000111833.82664.0c · Cited by 79 · cited 2×
“postmenopausal women is 33% lower than in the late follicular phase in premenopausal women.(162,163) In astrocytes, using immunohistochemistry and Western blot analysis, Arimoto et al(164) reported an increase in ERα levels with aging.”
Mechanisms of 17 β‐oestradiol induced vasodilatation in isolated pressurized rat small arteries
Shaw, L., Taggart, M. J., & Austin, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703084 · Cited by 78
PDE5 inhibitor efficacy is estrogen dependent in female heart disease
Sasaki, H., Nagayama, T., Blanton, R. M., Seo, K., Zhang, M., Zhu, G., Lee, D. I., Bedja, D., Hsu, S., Tsukamoto, O., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70731 · Cited by 75 · cited 1×
“failure of some small clinical trials could be related, at least in part, to sex differences in response to the drug.(9,10) In fact,”
Favre, J., Gao, J., Henry, J., Rémy‐Jouet, I., Fourquaux, I., Billon-Galés, A., Thuillez, C., Arnal, J., Lenfant, F., & Richard, V. J. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213637 · Cited by 75
Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat
Andersson, C., Lydrup, M. L., Fernö, M., Idvall, I., Gustafsson, J.-Å., & Nilsson, B. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690241 · Cited by 75 · cited 1×
“The expression level of ERs seems to vary with the sex.(38,158,159) Whether ER isoforms are distributed”
Ueda, K., Lu, Q., Baur, W., Aronovitz, M. J., & Karas, R. H. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300752 · Cited by 73 · cited 1×
“Consistent with these findings, a recent study showed that estrogen significantly blocks VSMC proliferation and decreases Akt phosphorylation because of enhanced protein phosphatase 2A activation mediated by a complex formed between ERα and protein phosphatase 2A.(111) They also used by gest on Sptem er 1, 2017 http:/…”
Holm, A., Baldetorp, B., Olde, B., Leeb-Lundberg, L. M. F., & Nilsson, B. (2011) · Journal of Vascular Research · doi:10.1159/000322578 · Cited by 71
Tan, E. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00159-5 · Cited by 70 · cited 1×
“endothelial nitric oxide synthase (eNOS), whereas in cardiac muscle, ERβ mediates upregulation of eNOS.(45,46) Also,”
Kawagoe, J., Ohmichi, M., Takahashi, T., Ohshima, C., Mabuchi, S., Takahashi, K., Igarashi, H., Mori-Abe, A., Saitoh, M., Du, B., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304363200 · Cited by 68 · cited 1×
“and activation resulting in enhanced expression of genes that contain an nuclear factor κ-light-chain-enhancer of activated B cells binding site.(155) The laboratory of Madak-Erdogan et al(156) recently reported that ≈25% of estrogen-regulated genes”
Smirnova, N. F., Fontaine, C., Buscato, M., Lupieri, A., Vinel, A., Valera, M., Guillaume, M., Malet, N., Foidart, J., Raymond‐Letron, I., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306416 · Cited by 67
Mahmoodzadeh, S. (2014) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000153 · Cited by 65
Lu, Q., Surks, H. K., Ebling, H., Baur, W. E., Brown, D., Pallas, D. C., & Karas, R. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210949200 · Cited by 64
Korte, T., Fuchs, M., Arkudas, A., Geertz, S., Meyer, R., Gardiwal, A., Klein, G. G., Niehaus, M., Krust, A., Chambon, P., et al. (2005) · Circulation · doi:10.1161/01.cir.0000164262.08004.bb · Cited by 64
Classical Estrogen Receptors and ERα Splice Variants in the Mouse
Irsik, D. L., Carmines, P. K., & Lane, P. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070926 · Cited by 62 · cited 16×
“In cardiomyocytes, Ullrich et al128 have shown that estrogendependent intracellular calcium signaling is independent of classic ERs: ERα and ERβ.”
InfluentialAge‐related changes in hypothalamic androgen receptor and estrogen receptor α in male rats
Wu, D., Lin, G. R., & Gore, A. C. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21925 · Cited by 61
Jeanes, H. L., Tabor, C. M., Black, D., EDERVEEN, A. G. H., & Gray, G. A. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0071 · Cited by 60
Estrogen Replacement and Cardiomyocyte Protection
Patten, R. D., & Karas, R. H. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.01.002 · Cited by 58 · cited 1×
“Additional studies with ovariectomized females have also shown that addition of estrogen reduces hypertrophy and I/R injury.(5) Figure 1 summarizes the cardiovascular effects associated with estrogen.”
Ullrich, N. D., Krust, A., Collins, P. D., & MacLeod, K. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01225.2007 · Cited by 57 · cited 1×
“Furthermore, removal of ERα and ERβ did not abolish estrogen-dependent responses in the cardiovascular system.(128) These results led to the suggestion that activation of GPER might be responsible for the vasodilatory effects of estrogen.”
Ortmann, J., Veit, M., Zingg, S., Di Santo, S., Traupe, T., Yang, Z., Völzmann, J., Dubey, R. K., Christen, S., & Baumgartner, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0943 · Cited by 51
Li, F., Yu, X., Szynkarski, C. K., Meng, C., Zhou, B., Barhoumi, R., White, R. E., Heaps, C. L., Stallone, J. N., & Han, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064771 · Cited by 50 · cited 1×
“Li et al recently demonstrated in coronary VSMCs that estrogen activation of GPER can decrease cell proliferation and migration.(143) Estrogen also has a role in regulating proliferation of vascular ECs, thus preventing excessive EC proliferation that can occur during atherosclerosis.”
Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2
Tsutsumi, S., Zhang, X., Takata, K., Takahashi, K., Karas, R. H., Kurachi, H., & Mendelsohn, M. E. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0292 · Cited by 49 · cited 16×
“In cardiomyocytes, Ullrich et al128 have shown that estrogendependent intracellular calcium signaling is independent of classic ERs: ERα and ERβ.”
InfluentialSpecific Regulation of Lipocalin-Type Prostaglandin D Synthase in Mouse Heart by Estrogen Receptor β
Otsuki, M., Gao, H., Dahlman‐Wright, K., Ohlsson, C., Eguchi, N., Urade, Y., & Gustafsson, J.-Α. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0016 · Cited by 49
Rubio‐Gayosso, I., Sierra-Ramírez, J. A., a-Vazquez, A. G., Martinez-Martinez, A., a, O. M. O.-G., Morato, T., & Ceballos, G. M. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200008000-00009 · Cited by 48 · cited 1×
“Treatment with estrogen conjugated to BSA caused a rise in calcium concentration in rat EC, whereas treatment with the ER antagonist ICI 182,780 blocked this effect.(106) Taken together, estrogen activation of membrane ERs leads to rapid signaling mechanisms that target nitric oxide signaling, thus modulating EC proli…”
Kararigas, G., Nguyen, B. T., & Jarry, H. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.011 · Cited by 48
Li, Q., Chen, L., Zhu, Y., Zhang, M., Wang, Y., & Wang, M. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.1 · Cited by 47 · cited 1×
“Several studies demonstrate that estrogen rapidly (within 30 minutes) inhibits VSMC proliferation.(107,108) On estrogen treatment, ERα stimulates the activity and expression of several phosphatases, such as MAP kinase phosphatase-1, Src homology region 2 domain-containing phosphatase-1, phosphatase and tensin homolog,…”
Zhang, X., Moor, A. N., Merkler, K. A., Liu, Q., & McLean, M. P. (2007) · Endocrinology · doi:10.1210/en.2007-0376 · Cited by 47
Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression
Hamilton, K. L., Lin, L., Wang, Y., & Knowlton, A. A. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00039.2007 · Cited by 46
Yang, L., Wang, Y., Chen, P., Hu, J., Xiong, Y., Feng, D., Liu, H., Zhang, H., Yang, H., & He, J. (2011) · Endocrinology · doi:10.1210/en.2011-1207 · Cited by 43
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells
Noël, D. D., Scafoglio, C., Rinaldi, A., Memoli, D., Giurato, G., Nassa, G., Ravo, M., Rizzo, F. M., Tarallo, R., & Weisz, A. (2015) · BMC Genomics · doi:10.1186/s12864-015-1541-1 · Cited by 41
Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation
Pechenino, A. S., Lin, L., Mbai, F. N., Lee, A. R., He, X.-M., Stallone, J. N., & Knowlton, A. A. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00228.2010 · Cited by 39
Han, G., Ma, H., Chintala, R., Fulton, D. J., Barman, S. A., & White, R. E. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149112 · Cited by 35
Cavasin, M. A., Stenmark, K. R., & McKinsey, T. A. (2015) · Pulmonary Circulation · doi:10.1086/679700 · Cited by 34 · cited 1×
“Histone deacetylase are important in regulation of cardiac hypertrophy: class II is involved in signaling that inhibit this disorder, whereas class I promotes hypertrophy.(115) Recently, Pedram et al(116) demonstrated that angiotensin regulates gene and protein level of both class I and II histone deacetylases and rap…”
Arimoto, J. M., Wong, A., Rozovsky, I., Lin, S. W., Morgan, T. E., & Finch, C. E. (2013) · Endocrinology · doi:10.1210/en.2012-2046 · Cited by 31
Devanathan, S., Whitehead, T., Schweitzer, G. G., Fettig, N. M., Kovács, A. D., Korach, K. S., Finck, B. N., & Shoghi, K. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101900 · Cited by 29
Interplay between estrogen receptor and AKT in Estradiol-induced alternative splicing
Bhat‐Nakshatri, P., Song, E. K., Collins, N., Uversky, V. N., Dunker, A. K., O’Malley, B. W., Geistlinger, T., Carroll, J. S., Brown, M. A., & Nakshatri, H. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-21 · Cited by 29
Point Mutations in the ERα Gαi Binding Domain Segregate Nonnuclear from Nuclear Receptor Function
Wu, Q., Chambliss, K. L., Lee, W.-R., Yuhanna, I. S., Mineo, C., & Shaul, P. W. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1378 · Cited by 25 · cited 1×
“Also, blocking formation of the ERα–Gαi complex prevented EC cell migration.(102) Recently, Chambliss et al(103) used EDC to demonstrate that EC proliferation and migration occurs via ERα–Gαi–Src kinase complex formation and resultant eNOS activation.”
Demethylation of Circulating Estrogen Receptor Alpha Gene in Cerebral Ischemic Stroke
Lin, H., Hsi, E., Liao, Y., Chhor, B., Hung, J., Juo, S. H., & Lin, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139608 · Cited by 23 · cited 1×
“Methylation of the ER promoter has been reported to increase with atherosclerosis,(166) but to decrease in brain after stroke.(167) In future studies, it will be important to better define”
Salgado, R. M., Covarrubias, A. E., Fávaro, R. R., Serrano‐Nascimento, C., Nunes, M. T., & Zorn, T. M. T. (2012) · Journal of Molecular Histology · doi:10.1007/s10735-012-9476-1 · Cited by 19 · cited 1×
“Mutation of this site blocked ERα translocation to the plasma membrane in cancer cell lines.(62) In 2007, Levin’s”
Sex, drugs, and trial design: sex influences the heart and drug responses
Murphy, E., & Steenbergen, C. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76262 · Cited by 13 · cited 1×
“failure of some small clinical trials could be related, at least in part, to sex differences in response to the drug.(9,10) In fact,”
Self-citationChen, L. C., & Lee, W.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084320 · Cited by 5 · cited 1×
“Furthermore, ERβ blocks inducible NOS gene upregulation in endothelial cells.(48) ERα and ERβ can”
Cited by
Iorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., & Eghbali, M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0152-8 · Cited by 914
“While there is abundant data supporting E2 as a cardoprotective agent in experimental models of CVD, E2 replacement therapy in postmenopausal women has been very controversial [5].”
BackgroundMaas, A. H. E. M., Rosano, G., Cifkova, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E., Lambrinoudaki, I., Maclaran, K., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa1044 · Cited by 344
Role of estrogen receptors in health and disease
Chen, P., Li, B., & Ou-Yang, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839005 · Cited by 339
Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?
Puhl, S.-L., & Steffens, S. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00025 · Cited by 196
Regulatory Actions of Estrogen Receptor Signaling in the Cardiovascular System
Ueda, K., Adachi, Y., Liu, P., Fukuma, N., & Takimoto, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00909 · Cited by 60
“These recent clinical findings encourage researchers to further investigate molecular and physiological function of ERmediated signaling in the cardiovascular system (12, 13), which provides meaningful steps forward to the development of a next generation of HT for women that capture the beneficial cardiovascular effe…”
Background
Metadata
- Authors
- Menazza, S., & Murphy, E.
- Venue
- Circulation Research
- Published
- 2016-03-18
- Volume
- 118
- Issue
- 6
- Pages
- 994-1007
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2226007603
- Cited by
- 210
- References
- 166
- FWCI
- 15.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.